UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Relationship between ADP-induced platelet-fibrin clot strength and anti-platelet responsiveness in ticagrelor treated ACS patients

Journal of geriatric cardiology : JGC, 2016-05, Vol.13 (4), p.282-289

2016

Volltextzugriff (PDF)

Mesenchymal Stem Cell Attenuates Neutrophil-predominant Inflammation and Acute Lung Injury in an In Vivo Rat Model of Ventilator-induced Lung Injury

Chinese medical journal, 2015-02, Vol.128 (3), p.361-367

2015

Volltextzugriff (PDF)

Taxonomic analysis of cryptococcus species complex strain $8012 revealed Cryptococcus gattii with high heterogeneity on the ~enetics

中华医学杂志：英文版, 2011 (13), p.2051-2056

CHEN Min LIAO Wan-qing WU Shao-xi YAO Zhi-rong PAN Wei-hua LIAO Yong

2011

Volltextzugriff (PDF)

Experimental detection of quantum entanglement

Frontiers of physics, 2013-08, Vol.8 (4), p.357-374

2013

Volltextzugriff (PDF)

Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy

Cell metabolism, 2023-01, Vol.35 (1), p.84-100.e8

2023

Volltextzugriff (PDF)

The microbial metabolite trimethylamine N-oxide promotes antitumor immunity in triple-negative breast cancer

Cell metabolism, 2022-04, Vol.34 (4), p.581-594.e8

2022

Volltextzugriff (PDF)

Monitoring Serum VEGF in Neoadjuvant Chemotherapy for Patients with Triple‐Negative Breast Cancer: A New Strategy for Early Prediction of Treatment Response and Patient Survival

The oncologist (Dayton, Ohio), 2019-06, Vol.24 (6), p.753-761

2019

Volltextzugriff (PDF)

Tektin4 loss promotes triple-negative breast cancer metastasis through HDAC6-mediated tubulin deacetylation and increases sensitivity to HDAC6 inhibitor

Oncogene, 2021-03, Vol.40 (12), p.2323-2334

2021

Volltextzugriff (PDF)

PD‐L1 expression of the residual tumor serves as a prognostic marker in local advanced breast cancer after neoadjuvant chemotherapy

International journal of cancer, 2017-03, Vol.140 (6), p.1384-1395

2017

Volltextzugriff (PDF)

Transcriptome Analysis of Triple-Negative Breast Cancer Reveals an Integrated mRNA-lncRNA Signature with Predictive and Prognostic Value

Cancer research (Chicago, Ill.), 2016-04, Vol.76 (8), p.2105-2114

2016

Volltextzugriff (PDF)

Integrated molecular profiling of young and elderly patients with triple‐negative breast cancer indicates different biological bases and clinical management strategies

Cancer, 2020-07, Vol.126 (14), p.3209-3218

2020

Volltextzugriff (PDF)

Value of CXCL8–CXCR1/2 axis in neoadjuvant chemotherapy for triple-negative breast cancer patients: a retrospective pilot study

Breast cancer research and treatment, 2020-06, Vol.181 (3), p.561-570

2020

Volltextzugriff (PDF)

Comprehensive transcriptome analysis identifies novel molecular subtypes and subtype-specific RNAs of triple-negative breast cancer

Breast cancer research : BCR, 2016-03, Vol.18 (1), p.33-33, Article 33

2016

Volltextzugriff (PDF)

Combined angiogenesis and PD-1 inhibition for immunomodulatory TNBC: concept exploration and biomarker analysis in the FUTURE-C-Plus trial

Molecular cancer, 2022-03, Vol.21 (1), p.84-84, Article 84

2022

Volltextzugriff (PDF)

Cyclophosphamide-Free Adjuvant Chemotherapy for Ovarian Protection in Young Women With Breast Cancer: A Randomized Phase 3 Trial

JNCI : Journal of the National Cancer Institute, 2021-10, Vol.113 (10), p.1352-1359

2021

Volltextzugriff (PDF)

PDSS1-Mediated Activation of CAMK2A-STAT3 Signaling Promotes Metastasis in Triple-Negative Breast Cancer

Cancer research (Chicago, Ill.), 2021-11, Vol.81 (21), p.5491-5505

2021

Volltextzugriff (PDF)

Molecular portraits and trastuzumab responsiveness of estrogen receptor-positive, progesterone receptor-positive, and HER2-positive breast cancer

Theranostics, 2019-01, Vol.9 (17), p.4935-4945

2019

Volltextzugriff (PDF)

Predictive and prognostic value of Matrix metalloproteinase (MMP) - 9 in neoadjuvant chemotherapy for triple-negative breast cancer patients

BMC cancer, 2018-09, Vol.18 (1), p.909-909, Article 909

2018

Volltextzugriff (PDF)

Characterization of the genomic landscape and actionable mutations in Chinese breast cancers by clinical sequencing

Nature communications, 2020-11, Vol.11 (1), p.5679-5679, Article 5679

2020

Volltextzugriff (PDF)

Comparison of hepatic resection and systemic treatment of breast cancer liver metastases: A propensity score matching study

The American journal of surgery, 2020-10, Vol.220 (4), p.945-951

2020

Volltextzugriff (PDF)

Curvature induced hierarchical wrinkling patterns in soft bilayers

Soft matter, 2016-09, Vol.12 (38), p.7977-7982

2016

Volltextzugriff (PDF)

IL1R2 Blockade Suppresses Breast Tumorigenesis and Progression by Impairing USP15‐Dependent BMI1 Stability

Advanced science, 2020-01, Vol.7 (1), p.1901728-n/a

2020

Volltextzugriff (PDF)

Inhibition of ACAA1 Restrains Proliferation and Potentiates the Response to CDK4/6 Inhibitors in Triple-Negative Breast Cancer

Cancer research (Chicago, Ill.), 2023-05, Vol.83 (10), p.1711-1724

2023

Volltextzugriff (PDF)

Value of Ki-67 expression in triple-negative breast cancer before and after neoadjuvant chemotherapy with weekly paclitaxel plus carboplatin

Scientific reports, 2016-07, Vol.6 (1), p.30091-30091, Article 30091

2016

Volltextzugriff (PDF)

1 – 25 von 131

Suche als RSS-Feed

Aktive Filter

ThemaBreast Neoplasms - Pathology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(110)
Mit Volltextzugriff
(112)

Publikationsform

Artikel
(131)

Sprache

Englisch
(123)
Chinesisch
(8)

Erscheinungsjahr

n.n

Thema

Science & Technology
(86)
Life Sciences & Biomedicine
(66)
Breast Cancer
(50)
Humans
(45)
Oncology
(41)
Female
(35)
Tumors
(23)
Middle Aged
(19)
Adult
(18)
Mutation
(17)
Prognosis
(15)
Chemotherapy
(14)
Cancer
(13)
Gene Expression
(13)
Metastasis
(13)
Patients
(13)
Triple Negative Breast Neoplasms - Pathology
(13)
Cancer Research
(12)
Cancer Therapies
(12)
Triple Negative Breast Neoplasms - Drug Therapy
(12)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Relationship between ADP-induced platelet-fibrin clot strength and anti-platelet responsiveness in ticagrelor treated ACS patients

Mesenchymal Stem Cell Attenuates Neutrophil-predominant Inflammation and Acute Lung Injury in an In Vivo Rat Model of Ventilator-induced Lung Injury

Taxonomic analysis of cryptococcus species complex strain $8012 revealed Cryptococcus gattii with high heterogeneity on the ~enetics

Experimental detection of quantum entanglement

Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy

The microbial metabolite trimethylamine N-oxide promotes antitumor immunity in triple-negative breast cancer

Monitoring Serum VEGF in Neoadjuvant Chemotherapy for Patients with Triple‐Negative Breast Cancer: A New Strategy for Early Prediction of Treatment Response and Patient Survival

Tektin4 loss promotes triple-negative breast cancer metastasis through HDAC6-mediated tubulin deacetylation and increases sensitivity to HDAC6 inhibitor

Cisplatin plus gemcitabine versus paclitaxel plus gemcitabine as first-line therapy for metastatic triple-negative breast cancer (CBCSG006): a randomised, open-label, multicentre, phase 3 trial

PD‐L1 expression of the residual tumor serves as a prognostic marker in local advanced breast cancer after neoadjuvant chemotherapy

Transcriptome Analysis of Triple-Negative Breast Cancer Reveals an Integrated mRNA-lncRNA Signature with Predictive and Prognostic Value

Integrated molecular profiling of young and elderly patients with triple‐negative breast cancer indicates different biological bases and clinical management strategies

Value of CXCL8–CXCR1/2 axis in neoadjuvant chemotherapy for triple-negative breast cancer patients: a retrospective pilot study

Comprehensive transcriptome analysis identifies novel molecular subtypes and subtype-specific RNAs of triple-negative breast cancer

Combined angiogenesis and PD-1 inhibition for immunomodulatory TNBC: concept exploration and biomarker analysis in the FUTURE-C-Plus trial

Cyclophosphamide-Free Adjuvant Chemotherapy for Ovarian Protection in Young Women With Breast Cancer: A Randomized Phase 3 Trial

PDSS1-Mediated Activation of CAMK2A-STAT3 Signaling Promotes Metastasis in Triple-Negative Breast Cancer

Molecular portraits and trastuzumab responsiveness of estrogen receptor-positive, progesterone receptor-positive, and HER2-positive breast cancer

Predictive and prognostic value of Matrix metalloproteinase (MMP) - 9 in neoadjuvant chemotherapy for triple-negative breast cancer patients

Characterization of the genomic landscape and actionable mutations in Chinese breast cancers by clinical sequencing

Comparison of hepatic resection and systemic treatment of breast cancer liver metastases: A propensity score matching study

Curvature induced hierarchical wrinkling patterns in soft bilayers

IL1R2 Blockade Suppresses Breast Tumorigenesis and Progression by Impairing USP15‐Dependent BMI1 Stability

Inhibition of ACAA1 Restrains Proliferation and Potentiates the Response to CDK4/6 Inhibitors in Triple-Negative Breast Cancer

Value of Ki-67 expression in triple-negative breast cancer before and after neoadjuvant chemotherapy with weekly paclitaxel plus carboplatin

Aktive Filter

Suchergebnisse filtern